These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38693750)

  • 1. A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
    Tane K; Shiono S; Wakabayashi M; Kataoka T; Mitome N; Fukuda H; Aokage K; Watanabe SI;
    Jpn J Clin Oncol; 2024 Aug; 54(8):926-929. PubMed ID: 38693750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the method of radiologic surveillance affect survival after resection of stage I non-small cell lung cancer?
    Crabtree TD; Puri V; Chen SB; Gierada DS; Bell JM; Broderick S; Krupnick AS; Kreisel D; Patterson GA; Meyers BF
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):45-52, 53.e1-3. PubMed ID: 25218540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance.
    Lou F; Huang J; Sima CS; Dycoco J; Rusch V; Bach PB
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):75-81; discussion 81-2. PubMed ID: 23127371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
    Kamigaichi A; Hamada A; Tsuboi M; Yoshimura K; Okamoto I; Yamamoto N; Tsutani Y
    Clin Lung Cancer; 2024 Jun; 25(4):384-388.e1. PubMed ID: 38360496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study).
    Shimoyama R; Tsutani Y; Wakabayashi M; Katayama H; Fukuda H; Suzuki K; Watanabe SI;
    Jpn J Clin Oncol; 2020 Sep; 50(10):1209-1213. PubMed ID: 32687185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
    Toba H; Sakiyama S; Otsuka H; Kawakami Y; Takizawa H; Kenzaki K; Kondo K; Tangoku A
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):859-64. PubMed ID: 22914804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer.
    Lou F; Sima CS; Rusch VW; Jones DR; Huang J
    Ann Thorac Surg; 2014 Nov; 98(5):1755-60; discussion 1760-1. PubMed ID: 25110337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?
    Subramanian M; Liu J; Greenberg C; Schumacher J; Chang GJ; McMurry TL; Francescatti AB; Semenkovich TR; Hudson JL; Meyers BF; Puri V; Kozower BD
    J Thorac Cardiovasc Surg; 2019 Mar; 157(3):1205-1217.e2. PubMed ID: 31130741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of newly detected lesions during postoperative surveillance for non-small cell lung cancer.
    Lee JI; Lee YJ; Park KY; Park CH; Jeon YB; Choi CH; Ko KP
    Ann Thorac Surg; 2013 Jun; 95(6):1867-71. PubMed ID: 23643548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
    Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
    Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.
    Yamamoto H; Soh J; Okumura N; Suzuki H; Nakata M; Fujiwara T; Gemba K; Sano I; Fujinaga T; Kataoka M; Terazaki Y; Fujimoto N; Kataoka K; Kosaka S; Yamashita M; Inokawa H; Inoue M; Nakamura H; Yamashita Y; Hotta K; Yoshioka H; Morita S; Matsuo K; Sakamoto J; Date H; Toyooka S
    PLoS One; 2023; 18(5):e0285273. PubMed ID: 37205678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.
    Mayne NR; Mallipeddi MK; Darling AJ; Jeffrey Yang CF; Eltaraboulsi WR; Shoffner AR; Naqvi IA; D'Amico TA; Berry MF
    Clin Lung Cancer; 2020 Sep; 21(5):407-414. PubMed ID: 32376115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging surveillance and survival for surgically resected non-small-cell lung cancer.
    Backhus LM; Farjah F; Liang CK; He H; Varghese TK; Au DH; Flum DR; Zeliadt SB
    J Surg Res; 2016 Jan; 200(1):171-6. PubMed ID: 26231974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography surveillance scanning after lung cancer surgery: mathematical optimization of scanning interval based on tumour biology.
    Poullis M
    Interact Cardiovasc Thorac Surg; 2014 Feb; 18(2):149-52. PubMed ID: 24227882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
    Westeel V; Foucher P; Scherpereel A; Domas J; Girard P; Trédaniel J; Wislez M; Dumont P; Quoix E; Raffy O; Braun D; Derollez M; Goupil F; Hermann J; Devin E; Barbieux H; Pichon E; Debieuvre D; Ozenne G; Muir JF; Dehette S; Virally J; Grivaux M; Lebargy F; Souquet PJ; Freijat FA; Girard N; Courau E; Azarian R; Farny M; Duhamel JP; Langlais A; Morin F; Milleron B; Zalcman G; Barlesi F
    Lancet Oncol; 2022 Sep; 23(9):1180-1188. PubMed ID: 35964621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
    Zhou Q; Shi Y; Chen J; Liu B; Wang Y; Zhu D; Zhang HT; Xu P; Gong Y; Chen G; Wei S; Qiu X; Niu Z; Chen X; Lei Z; Duan L; Wu Z
    Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):86-106. PubMed ID: 21342639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study.
    Tsuchiya T; Matsumoto K; Miyazaki T; Doi R; Tokunaga S; Yamaguchi H; Tomoshige K; Watanabe H; Nagayasu T; Sugio K
    BMC Cancer; 2021 Mar; 21(1):249. PubMed ID: 33685421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE).
    Tanaka K; Tsutani Y; Wakabayashi M; Mizutani T; Aokage K; Miyata Y; Kuroda H; Saji H; Watanabe SI; Okada M;
    Jpn J Clin Oncol; 2020 Sep; 50(9):1076-1079. PubMed ID: 32548619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413).
    Hishida T; Saji H; Watanabe SI; Asamura H; Aokage K; Mizutani T; Wakabayashi M; Shibata T; Okada M;
    Jpn J Clin Oncol; 2018 Feb; 48(2):190-194. PubMed ID: 29177507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.